0 false false false false false false false true false false true false false false false false false No description of principal activity 2023-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 12155895 2023-01-01 2023-12-31 12155895 2023-12-31 12155895 2022-12-31 12155895 2022-01-01 2022-12-31 12155895 2022-12-31 12155895 2021-12-31 12155895 bus:Director1 2023-01-01 2023-12-31 12155895 core:WithinOneYear 2023-12-31 12155895 core:WithinOneYear 2022-12-31 12155895 core:ShareCapital 2023-12-31 12155895 core:ShareCapital 2022-12-31 12155895 core:RetainedEarningsAccumulatedLosses 2023-12-31 12155895 core:RetainedEarningsAccumulatedLosses 2022-12-31 12155895 bus:SmallEntities 2023-01-01 2023-12-31 12155895 bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 12155895 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 12155895 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 12155895 bus:FullAccounts 2023-01-01 2023-12-31
COMPANY REGISTRATION NUMBER: 12155895
Vitabiotics Distribution Ltd
Filleted Unaudited Financial Statements
31 December 2023
Vitabiotics Distribution Ltd
Statement of Financial Position
31 December 2023
2023
2022
Note
£
£
Current assets
Debtors
4
766,598
766,598
Cash at bank and in hand
15,314
15,314
---------
---------
781,912
781,912
Creditors: amounts falling due within one year
5
787,457
787,457
---------
---------
Net current liabilities
5,545
5,545
-------
-------
Total assets less current liabilities
( 5,545)
( 5,545)
-------
-------
Capital and reserves
Called up share capital
1
1
Profit and loss account
( 5,546)
( 5,546)
-------
-------
Shareholder deficit
( 5,545)
( 5,545)
-------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The company did not trade during the year and has not made either a profit or loss.
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 15 August 2024 , and are signed on behalf of the board by:
Mr T Lalvani
Director
Company registration number: 12155895
Vitabiotics Distribution Ltd
Notes to the Financial Statements
Year ended 31 December 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 1 Apsley Way, London, NW2 7HF.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The financial statements have been prepared on the going concern basis, not withstanding the net liabilities on the basis that the company's immediate parent company has provided the company with an undertaking that it will not seek repayment of its dues for the foreseeable future.
Income statement
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price.
4. Debtors
2023
2022
£
£
Amounts owed by group undertakings and undertakings in which the company has a participating interest
766,598
766,598
---------
---------
5. Creditors: amounts falling due within one year
2023
2022
£
£
Amounts owed to group undertakings and undertakings in which the company has a participating interest
787,457
787,457
---------
---------
6. Related party transactions
The company has taken advantage of the exemption granted by paragraph 33.1(a) of FRS102, Related Party Disclosures, not to disclose transactions with group companies which are wholly owned subsidiaries of the group.